Optiray 350 741 mg/mL

Optiray 350 741 mg/mL is a radiopaque contrast agent used for diagnostic imaging procedures. This injection, containing ioversol, aids in enhancing visibility during X-ray and CT scans. Ideal for intra-arterial and intravenous administration, it is manufactured by Liebel-Flarsheim Company LLC in the USA.

Optiray 350 741 mg/mL is primarily used as a contrast medium to improve the clarity of images during diagnostic imaging. It is commonly administered for procedures such as angiography and computed tomography (CT) scans. The ioversol in Optiray 350 helps to highlight blood vessels and other structures, making it easier for healthcare professionals to detect abnormalities. This contrast agent is suitable for both intra-arterial and intravenous routes, providing versatility in various diagnostic settings.

When administered, Optiray 350 741 mg/mL may cause a temporary warm sensation or a metallic taste in the mouth. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly. It is important to note that individual responses can vary, and not everyone will experience these effects.

Optiray 350 741 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast agents. It is essential to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are crucial to maintain the integrity of the product. Always follow the guidelines provided by healthcare professionals for safe and effective use.

Optiray 350 741 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to consult with a healthcare provider before using this contrast agent if you are taking other medications. Additionally, individuals with kidney issues should be monitored closely during and after administration to ensure safety.